VI. BIBLIOGRAPHIE
Aberle AM, Tablin F, Zhu J, Walker NJ, Gruenert DC, Nantz MH. 1998. A novel tetraester
construct that reduces catloni'c lipid-associated cytotoxicity. Implications for the onset of
cytotoxicity. Biochemistry 37:6533-40.
Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. 1993. Cloning of a rat adipocyte
membrane protein implicated in binding or transport of long-chain fatty acids that is induced
during preadipocyte différentiation. Homology with human CD36. J Biol Chem 268:17665-8.
Akita H, Ito R, Khalil lA, Futaki S, Narashima H. 2004. Quantitative three-dimensional analysis
of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery System
using confocal laser scanning microscopy. Mol Ther 9:443-51.
Aliberti J, Hieny S, Reis e Sousa C, Serhan CN, Sher A. 2002. Lipoxin-mediated inhibition of IL-
12 production by DCs: a mechanism for régulation of microbial immunity. Nat Immunol 3:76-
82.
Allan D, Payares G, Evans WH. 1987. The phospholipid and fatty acid composition of
Schistosoma mansoni and of its purified tegumental membranes. Mol Biochem Parasitol
23:123-8.
Alton EW, Stern M, Farley R, Jaffe A, Chadwick SL, Phillips J, Davies J, Smith SN, Browning J,
Davies MG, Hodson ME, Durham SR, Li D, Jeffery PK, Scallan M, Balfour R, Eastman SJ, Cheng
SH, Smith AE, Meeker D, Geddes DM. 1999. Cationic lipid-mediated CFTR gene transfer to the
lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet
353:947-54.
Alving CR. 1992. Immunologie aspects of liposomes: présentation and Processing of liposomal
protein and phospholipid antigens. Biochim Biophys Acta. 1113:307-22.
Alving CR. 1995. Liposomal vaccines: clinical status and immunological présentation for
humoral and cellular immunity. Ann N Y Acad Sci : 754:143-52.
Aramaki Y, Takano S, Tsuchiya S. 1999. Induction of apoptosis in macrophages by cationic
liposomes. FEBS Lett. 460:472-6.
Aramaki Y. 2000. Liposomes as immunomodulator-inhibitory effect of liposomes on NO
production from macrophages. Biol Pharm Bull. 23:1267-74.
Aramaki Y, Takano S, Tsuchiya S. 2001. Cationic liposomes induce macrophage apoptosis
through mitochondrial pathway. Arch Biochem Biophys. 392:245-50.
Arima H, Aramaki Y, Tsuchiya S. 1997. Contribution of trypsin-sensitive proteins to binding of
cationic liposomes to the mouse macrophage-like cell line RAW264.7. J Pharm Sci. 86:786-90.
Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN.
2005. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3
lipid mediator resolvin El. J Exp Med. 201:713-22.
Baatz JE, Zou Y, Korfhagen TR. 2001. Inhibitory effects of tumor necrosis factor-alpha on
cationic lipid-mediated gene delivery to airway cells in vitro. Biochim Biophys Acta. 1535:100-
9.
Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. 2003. Differential effects of
prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2
expression and IL-6 sécrétion. Proc Natl Acad Sci USA. 100:1751-6.
Barham JB, Edens MB, Fonteh AN, Johnson MM, Easter L, Chilton FH. 2000. Addition of
eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents sérum
arachidonic acid accumulation in humans. J Nutr. 130:1925-31.
Barre E. 2003. A more detailed fatty acid composition of human lipoprotein(a)-a comparison
with low density lipoprotein. Chem Phys Lipids. 123:99-105.
Barton GM, Medzhitov R. 2003. Toll-like receptor signaling pathways. Science. 300:1524-5.
Becker S, Quay J, Koren HS, HaskiU JS. 1994. Constitutive and stimulated MCP-1, GRO alpha,
beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages.
Am J Physiol. 266:L278-86.
Bell PC, Bergsma M, Dolbnya IP, Bras W, Stuart MC, Rowan AE, Feiters MC, Engberts JB. 2003.
Transfection mediated by gemini surfactants: engineered escape from the endosomal
compartment. J Am Chem Soc. 125:1551-8.
Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J
Biochem Physiol. 37:911-7.
Bochkov VN, Kadl A, Huber J, Gruber F, Binder BR, Leitinger N. 2002a. Protective rôle of
phospholipid oxidation products in endotoxin-induced tissue damage. Nature. 419:77-81.
Bochkov VN, Mechtcheriakova D, Lucerna M, Huber J, Malli R, Graier WF, Hofer E, Binder BR,
Leitinger N. 2002b. Oxidized phospholipids stimulate tissue factor expression in human
endothélial cells via activation of ERK/EGR-1 and Ca(++)/NFAT. Blood. 99:199-206.
Bochkov VN, Leitinger N. 2003. Anti-inflammatory properties of lipid oxidation products. J Mol
Med. 81:613-26.
Bottega R, Epand RM. 1992. Inhibition of protein kinase C by cationic amphiphiles.
Biochemistry. 31:9025-30.
Bottino R, Fernandez LA, Ricordi C, Lehmann R, Tsan MF, Oliver R, Inverardi L. 1998.
Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage
déplétion on graft survival and microenvironment activation. Diabètes. 47:316-23.
Boukhnikachvili T, Aguerre-Chariol O, Airiau M, Lesieur S, Ollivon M, Vacus J. 1997. Structure
of in-serum transfecting DNA-cationic lipid complexes. FEBS Lett. 409:188-94.
Boullier A, Friedman P, Harkewicz R, Hartvigsen K, Green SR, Almazan F, Dennis EA, Steinberg
D, Witztum JL, Quehenberger O. 2005. Phosphocholine as a pattern récognition ligand for
CD36. J Lipid Res. 46:969-76.
Brentano F, Schorr O, Gay RE, Gay S, Kyburz D. 2005. RNA released from necrotic synovial
fluid cells activâtes rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis
Rheum. 52:2656-65.
Brodskyn C, Patricio J, Oliveira R, Lobo L, Arnholdt A, Mendonca-Previato L, Barrai A, Barral-
Netto M. 2002. Glycoinositolphospholipids from Trypanosoma cruzi interfère with
macrophages and dendritic cell responses. Infect Immun. 70:3736-43.
Brouwers JF, Van Hellemond JJ, van Golde LM, Tielens AG. 1998a. Ether lipids and their
possible physiological fonction in adult Schistosoma mansoni. Mol Biochem Parasitol. 96:49-
58.
Brouwers JF, Gadella BM, van Golde LM, Tielens AG. 1998b. Quantitative analysis of
phosphatidylcholine molecular species using HPLC and light scattering détection. J Lipid Res.
39:344-53.
Brown MD, Schatzlein AG, Uchegbu IF. 2001. Gene delivery with synthetic (non viral) carriers.
Int J Pharm. 229:1-21.
Brunei F, Darbouret A, Ronco J. 1999. Cationic lipid DC-Chol induces an improved and
balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine.
Vaccine. 17:2192-203.
Brunner S, Sauer T, Carotta S, Cotten M, Saltik M, Wagner E. 2000. Cell cycle dependence of
gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. 7:401-7.
Calder PC. 2005. Polyunsaturated fatty acids and inflammation. Biochem Soc Trans. 33:423-7.
Capaccioli S, Di Pasquale G, Mini E, Mazzei T, Quattrone A. 1993. Cationic lipids improve
antisense oligonucleotide uptake and prevent dégradation in cultured cells and in human
sérum. Biochem Biophys Res Commun. 197:818-25.
Caplen NJ, Kinrade E, Sorgi F, Gao X, Gruenert D, Geddes D, Coutelle C, Huang L, Alton EW,
Williamson R. 1995. In vitro liposome-mediated DNA transfection of épithélial cell Unes using
the cationic liposome DC-Chol/DOPE. Gene Ther. 2:603-13.
Chapman AAJ. 1986. Comparative analysis of mammalian plasma lipoproteins. Methods
Enzymol.128:70-143.
Cherezov V, Qiu H, Pector V, Vandenbranden M, Ruysschaert JM, Caffrey M. 2002. Biophysical
and transfection studies of the diC(14)-amidine/DNA complex. Biophys J. 82:3105-17.
Chesnoy S, Huang L. 2000. Structure and function of lipid-DNA complexes for gene delivery.
Annu Rev Biophys Biomol Struct. 29:27-47.
Chinetti G, Gbaguidi FG, Griglio S, Mallat Z, Antonucci M, Poulain P, Chapman J, Fruchart JC,
Tedgui A, Najib-Fruchart J, Staels B. 2000. CLA-1/SR-BI is expressed in atherosclerotic lésion
macrophages and regulated by activators of peroxisome proliferator-activated receptors.
Circulation. 101:2411-7.
Chung SW, Kang BY, Kim SH, Pak YK, Cho D, Trinchieri G, Kim TS. 2000. Oxidized low density
lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse
macrophages via direct interactions between peroxisome proliferator-activated receptor-
gamma and nuclear factor-kappa B. J Biol Chem. 275:32681-7.
Cippitelli M, Fionda C, Di Bona D, Lupo A, Piccoli M, Frati L, Santoni A. 2003. The
cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95
ligand gene expression in T lymphocytes: interférence with promoter activation via
peroxisome proliferator-activated receptor-gamma-independent mechanisms. J Immunol.
170:4578-92.
Coonrod A, Li FQ, Horwitz M. 1997. On the mechanism of DNA transfection: efficient gene
transfer without viruses. Gene Ther. 4:1313-21.
Cornelis S, Vandenbranden M, Ruysschaert JM, Elouahabi A. 2002. Rôle of intracellular
cationic liposome-DNA complex dissociation in transfection mediated by cationic lipids. DNA
Cell Biol. 21:91-7.
Coûtant F, Perrin-Cocon L, Agaugue S, Delair T, André P, Lotteau V. 2002. Mature dendritic
cell génération promoted by lysophosphatidylcholine. J Immunol. 169:1688-95.
Dalby B, Cates S, Harris A, Ohki EC, Tilkins ML, Price PJ, Ciccarone VC. 2004. Advanced
transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput
applications. Methods. 33:95-103.
Dalkara D, Zuber G, Behr JP. 2004. Intracytoplasmic delivery of anionic proteins. Mol Ther.
9:964-9.
Dan N. 1998. The structure of DNA complexes with catlonic liposomes-cylindrical or fiat
bilayers? Biochim Biophys Acta. 1369:34-8.
Davies SS, Pontsler AV, Marathe GK, Harrison KA, Murphy RC, Hinshaw JC, Prestwich GD,
Hilaire AS, Prescott SM, Zimmerman GA, Mcintyre TM. 2001. Oxidized alkyl phospholipids are
spécifie, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists.
J Biol Chem. 276:16015-23.
Daynes RA, Jones DC. 2002. Emerging rôles of PPARs in inflammation and immunity. Nat Rev
Immunol. 2:748-59.
Defrise-Quertain F, Duquenoy P, Brasseur R, Brak P, Caillaux B, Fuks R, Ruysschaert JM. 1986.
Vesicle formation by double long-chain amidines. J Chem Soc, Chem Commun. 1060-1062
De Laporte L, Cruz Rea J, Shea LD. 2006. Design of modular non-viral gene therapy vectors.
Biomaterials. 27:947-54.
De Libero G, Mori L. 2006. How T lymphocytes recognize lipid antigens. FEBS Lett. 580:5580-
7.
Dean DA. 1997. Import of plasmid DNA into the nucléus is sequence spécifie. Exp Cell Res.
230:293-302.
Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC,
Tedgui A, Haegeman G, Staels B. 1999a. Peroxisome proliferator-activated receptor alpha
negatively régulâtes the vascular inflammatory gene response by négative cross-talk with
transcription factors NF-kappaB and AP-1. J Biol Chem. 274:32048-54.
Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchart JC, Najib J, Duriez P, Staels B.
1999b. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced
endothelin-1 production in human vascular endothélial cells by inhibiting the activator
protein-1 signaling pathway. Cire Res. 85:394-402.
Delerive P, Furman C, Teissier E, Fruchart J, Duriez P, Staels B. 2000a. Oxidized phospholipids
activate PPARalpha in a phospholipase A2-dependent manner. FEBS Lett. 471:34-8.
Delerive P, Gervois P, Fruchart JC, Staels B. 2000b. Induction of IkappaBalpha expression as a
mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-
activated receptor-alpha activators. J Biol Chem. 275:36703-7.
Delerive P, Fruchart JC, Staels B. 2001. Peroxisome proliferator-activated receptors in
inflammation control. J Endocrinol. 169:453-9.
Desreumaux P, Dubuquoy L, Nutten S, Peuchmaur M, Englaro W, Schoonjans K, Derijard B,
Desvergne B, Wahli W, Chambon P, Leibowitz MD, Colombel JF, Auwerx J. 2001. Atténuation
of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome
proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new
therapeutic strategies. J Exp Med. 193:827-38.
Devehand PR, Arita M, Hong S, Bannenberg G, Moussignac RL, Gronert K, Serhan CN. 2003.
Human ALX receptor régulâtes neutrophil recruitment in transgenic mice: rôles in
inflammation and host defense. FASEB J. 17:652-9.
Dooper AAM, Wassink L, M'Rabet L, Graus YM. 2002. The modulatory effects of prostaglandin-E
on cytokine production by human peripheral blood mononuclear cells are independent of the
prostaglandin subtype. Immunology. 107:152-9.
Dow SW, Fradkin LG, Liggitt DH, Willson AP, Heath TD, Potter TA. 1999. Lipid-DNA complexes
induce potent activation of innate immune responses and antitumor activity when
administered intravenously. J Immunol. 163:1552-61.
Dov^y ME, Williams P, Zhang G, Hagstrom JE, Wolff JA. 1995. Plasmid DNA entry into
postmitotic nuclei of primary rat myotubes. Proc Natl Acad Sci USA. 92:4572-6.
Driscoll KE, Hassenbein DG, Carter J, Poynter J, Asquith TN, Grant RA, Whitten J, Purdon MP,
Takigiku R. 1993. Macrophage inflammatory proteins 1 and 2: expression by rat alveolar
macrophages, fibroblasts, and épithélial cells and in rat lung after minerai dust exposure. Am
J Respir Cell Mol Biol. 8:311-8.
Eastman SJ, Siegel C, Tousignant J, Smith AE, Cheng SH, Scheule RK. 1997. Biophysical
characterization of cationic lipid: DNA complexes. Biochim Biophys Acta. 1325:41-62.
Edwards PA, Kennedy AAA, Mak PA. 2002. LXRs; oxysterol-activated nuclear receptors that
regulate genes controlling lipid homeostasis. Vascul Pharmacol. 38:249-56.
El-Aneed A. 2004. An OverView of current delivery Systems in cancer gene therapy. J Control
Release. 94:1-14.
El Ouahabi A, Pector V, Fuks R, Vandenbranden M, Ruysschaert JM. 1996. Double long-chain
amidine liposome-mediated self replicating RNA transfection. FEBS Lett. 380:108-12.
El Ouahabi A, Thiry M, Pector V, Fuks R, Ruysschaert JM, Vandenbranden M. 1997. The rôle of
endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS
Lett. 414:187-92.
El Ouahabi A, Thiry M, Schiffmann S, Fuks R, Nguyen-Tran H, Ruysschaert JM, Vandenbranden
M. 1999. Intracellular visualization of BrdU-labeled plasmid DNA/cationic liposome
complexes. J Histochem Cytochem. 47:1159-66.
Elouahabi A, Flamand V, Ozkan S, Paulart F, Vandenbranden M, Goldman M, Ruysschaert JM.
2003a. Free cationic liposomes inhibit the inflammatory response to cationic lipid-DNA
complex injected intravenously and enhance its transfection efficiency. Mol Ther. 7:81-8.
Elouahabi A, Thiry M, Pector V, Ruysschaert JM, Vandenbranden M. 2003b. Calorimetry of
cationic liposome-DNA complex and intracellular visualization of the complexes. Methods
Enzymol. 373:313-32.
Elouahabi A, Ruysschaert JM. 2005. Formation and intracellular trafficking of lipoplexes and
polyplexes. Mol Ther. 11:336-47.
Escriou V, Ciolina C, Lacroix F, Byk G, Scherman D, Wils P. 1998. Cationic lipid-mediated gene
transfer: effect of sérum on cellular uptake and intracellular fate of lipopolyamine/DNA
complexes. Biochim Biophys Acta. 1368:276-88.
Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for
phosphatidylserine-specific clearance of apoptotic cells. Nature. 2000 May 4;405(6782):85-90.
Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. 1998. Macrophages
that hâve ingested apoptotic cells in vitro inhibit proinflammatory cytokine production
through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest.
101:890-8.
Farhood H, Bottega R, Epand RM, Huang L. 1992. Effect of cationic cholestérol dérivatives on
gene transfer and protein kinase C activity. Biochim Biophys Acta. 1111:239-46.
Farhood H, Serbina N, Huang L. 1995. The rôle of dioleoyl phosphatidylethanolamine in
cationic liposome mediated gene transfer. Biochim Biophys Acta. 1235:289-95.
Fasbender A, Marshall J, Moninger TO, Grunst T, Cheng S, Welsh MJ. 1997. Effect of co-lipids
in enhandng cationic lipid-mediated gene transfer in vitro and in vivo. Gene Ther. 4:716-25.
Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL. 1999. A
null mutation in murine CD36 reveals an important rôle in fatty acid and lipoprotein
metabolism. J Biol Chem. 274:19055-62.
Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM,
Danielsen M. 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection
procedure. Proc Natl Acad Sci USA. 84:7413-7.
Felgner PL, Ringold GM. 1989. Cationic liposome-mediated transfection. Nature. 337:387-8.
Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Felgner
PL. 1994. Enhanced gene delivery and mechanism studies with a novel sériés of cationic lipid
formulations. J Biol Chem. 269:2550-61.
Ferrante JV, Huang ZH, Nandoskar M, Hii CS, Robinson BS, Rathjen DA, Poulos A, Morris CP,
Ferrante A. 1997. Altered responses of human macrophages to lipopolysaccharide by
hydroperoxy eicosatetraenoic acid, hydroxy eicosatetraenoic acid, and arachidonic acid.
Inhibition of tumor necrosis factor production. J Clin Invest. 99:1445-52.
Filion MC, Phillips NC. 1997a. Toxicity and immunomodulatory activity of liposomal vectors
formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta.
1329:345-56.
Filion MC, Phillips NC. 1997b. Anti-inflammatory activity of cationic lipids. Br J Pharmacol.
122:551-7.
Friend DS, Papahadjopoulos D, Debs RJ. 1996. Endocytosis and intracellular Processing
accompanying transfection mediated by cationic liposomes. Biochim Biophys Acta. 1278:41-
50.
Fukasawa M, Adachi H, Hirota K, Tsujimoto M, Arai H, Inoue K. 1996. SRB1, a class B
scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp
Cell Res. 222:246-50.
Gao X, Huang L. 1991. A novel cationic liposome reagent for efficient transfection of
mammalian cells. Biochem Biophys Res Commun. 179:280-5.
Gershon H, Ghirlando R, Guttman SB, Minsky A. 1993. Mode of formation and structural
features of DNA-cationic liposome complexes used for transfection. Biochemistry. 32:7143-51.
Ghosh YK, Visweswariah SS, Bhattacharya S. 2000. Nature of linkage between the cationic
headgroup and cholesteryl skeleton Controls gene transfection efficiency. FEBS Lett. 473:341-
4.
Gilbreath MJ, Swartz GM Jr, Alving CR, Nacy CA, Hoover DL, Meltzer MS. 1985. Differential
inhibition of macrophage microbicidal activity by liposomes. Infect Immun. 47:567-9.
Gosset P, Bureau F, Angeli V, Pichavant M, Faveeuw C, Tonnel AB, Trottein F. 2003.
Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells:
conséquence on the polarization of naiveTh cells. J Immunol. 170:4943-52.
Graler MH, Goetzl EJ. 2002. Lysophospholipids and their G protein-coupled receptors in
inflammation and immunity. Biochim Biophys Acta. 1582:168-74.
Gregoriadis G, Bacon A, Caparros-Wanderley W, McCormack B. 2002. A rôle for liposomes in
genetic vaccination. Vaccine. 20 Suppl 5:B1-9.
-Gregoriadis G. 1994. Liposomes as immunoadjuvants and vaccine carriers: antigen
entrapment. Immunomethods. 4:210-6.
Gumperz JE. 2006. The ins and outs of GDI molécules: bringing lipids under immunological
surveillance. Traffic. 7:2-13.
Guo X, Szoka FC Jr. 2003. Chemical approaches to triggerable lipid vesicles for drug and gene
delivery. Acc Chem Res. 36:335-41.
Guy B, Pascal N, Francon A, Bonnin A, Gimenez S, Lafay-Vialon E, Trannoy E, Haensler J.
2001. Design, characterization and preclinical efficacy of a cationic lipid adjuvant for
influenza split vaccine. Vaccine. 19:1794-805.
Hacker H, Mischak H, Miethke T, Liptay S, Schmid R, Sparwasser T, Heeg K, Lipford GB,
Wagner H. 1998. CpG-DNA-specific activation of antigen-presenting cells requires stress
kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO
J. 17:6230-40.
Hamilton TA, Ma GP, Chisolm GM. 1990. Oxidized low density lipoprotein suppresses the
expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal
macrophages. J Immunol. 144:2343-50.
Hampton RY, Golenbock DT, Penman M, Krieger M, Raetz CR. 1991. Récognition and plasma
clearance of endotoxin by scavenger receptors. Nature. 352:342-4.
Hardonk MJ, Dijkhuis FW, Hulstaert CE, Koudstaal J. 1992. Heterogeneity of rat liver and
spleen macrophages in gadolinium chloride-induced élimination and repopulation. J Leukoc
Biol. 52:296-302.
Hargreaves DC, Medzhitov R. 2005. Innate sensors of microbial infection. J Clin Immunol.
25:503-10.
Harrington JJ, Van Bokkelen G, Mays RW, Gustashav/ K, Willard HF. 1997. Formation of de
novo centromeres and construction of first-generation human artificial microchromosomes.
Nat Genet. 15:345-55.
Hashimoto M, Asai Y, Ogawa T. 2003. Treponemal phospholipids inhibit innate immune
responses induced by pathogen-associated molecular patterns. J Biol Chem. 278:44205-13.
Haworth R, Platt N, Keshav S, Hughes D, Darley E, Suzuki H, Kurihara Y, Kodama T, Gordon S.
1997. The macrophage scavenger receptor type A is expressed by activated macrophages and
protects the host against léthal endotoxic shock. J Exp Med. 186:1431-9.
Hevonoja T, Pentikainen MO, Hyvonen MT, Kovanen PT, Ala-Korpela M. 2000. Structure of low
density lipoprotein (LDL) particles: basis for understanding molecular changes in modified
LDL. Biochim Biophys Acta : 1488(3):189-210.
Hirota S, de llarduya CT, Barron LG, Szoka FC Jr. 1999. Simple mixing device to reproducibly
préparé cationic lipid-DNA complexes (lipoplexes). Biotechniques. 27:286-90.
Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ. 2001. Lysophospholipids-receptor révélations.
Science. 294:1875-8.
Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T,
Zahringer U, Beutler B. 2005. CD36 is a sensor of diacylglycerides. Nature. 433:523-7.
Hoffmann PR, Kench JA, Vondracek A, Kruk E, Daleke DL, Jordan M, Marrack P, Henson PM,
Fadok VA. 2005. Interaction between phosphatidylserine and the phosphatidylserine receptor
inhibits immune responses in vivo. J Immunol. 174:1393-404.
Hofman CR, Dileo JP, U Z, Li S, Huang L. 2001. Efficient in vivo gene transfer by PCR
amplified fragment with reduced inflammatory activity. Gene Ther. 8:71-4.
Hong K, Zheng W, Baker A, Papahadjopoulos D. 1997. Stabilization of cationic liposome-
plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for
efficient in vivo gene delivery. FEBS Lett. 400:233-7.
Hui SW, Langner M, Zhao YL, Ross P, Hurley E, Chan K. 1996. The rôle of helper lipids in
cationic liposome-mediated gene transfer. Biophys J. 71:590-9.
Huynh ML, Fadok VA, Henson PM. 2002. Phosphatidylserine-dependent ingestion of apoptotic
cells promotes TGF-betal sécrétion and the resolution of inflammation. J Clin Invest. 109:41-
50.
Hyde SC, Southern KW, Gileadi U, Fitzjohn EM, Mofford KA, Waddell BE, Gooi HC, Goddard
CA, Hannavy K, Smyth SE, Egan JJ, Sorgi FL, Huang L, Cuthbert AW, Evans AAJ, Colledge WH,
Higgins CF, Webb AK, GUI DR. 2000. Repeat administration of DNA/liposomes to the nasal
epithelium of patients with cystic fibrosis. Gene Ther. 7:1156-65.
Idzko M, Panther E, Corinti S, Morelli A, Ferrari D, Herouy Y, Dichmann S, Mockenhaupt M,
Gebicke-Haerter P, Di Virgilio F, Girolomoni G, Norgauer J. 2002. Sphingosine 1-phosphate
induces chemotaxis of immature and modulâtes cytokine-release in mature human dendritic
cells for emergence of Th2 immune responses. FASEB J. 16:625-7.
Jacquet A, Vanderschrick JF, Vandenbranden M, Elouahabi A, Magi M, Garcia L, Ruysschaert
JM. 2005. Vaccination with the recombinant allergen ProDer p 1 complexed with the cationic
lipid DiC14-amidine prevents allergie responses to house dust mite. Mol Ther. 11:960-8.
Jenson JS, O'Connor R, Osborne J, Devaney E. 2002. Infection with Brugia microfilariae
induces apoptosis of CD4(+) T lymphocytes: a mechanism of immune unresponsiveness in
filariasis. Eur J Immunol. 32:858-67.
Kadl A, Huber J, Gruber F, Bochkov VN, Binder BR, Leitinger N. 2002. Analysis of
inflammatory gene induction by oxidized phospholipids in vivo by quantitative real-time RT-
PCR in comparison with effects of LPS. Vascul Pharmacol. 38:219-27.
Kamiya H, Fujimura Y, Matsuoka I, Harashima H. 2002. Visualization of intracellular
trafficking of exogenous DNA delivered by cationic liposomes. Biochem Biophys Res Commun.
298:591-7.
Karin M, Takahashi T, Kapahi P, Delhase M, Chen Y, Makris C, Rothwarf D, Baud V, Natoli G,
Guido F, Li N. 2001. Oxidative stress and gene expression: the AP-1 and NF-kappaB
connections. Biofactors. 15:87-9.
Karmali PP, Chaudhuri A. 2006. Cationic liposomes as non-viral carriers of gene medicines:
Resolved issues, open questions, and future promises. Med Res Rev. Oct 4.
Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y. 1997. Docosahexaenoic and
eicosapentaenoic acids inhibit in vitro human endothélial cell production of interleukin-6. Adv
Exp Med Biol. 400B: 589-97.
Kitchens RL, Ulevitch RJ, Munford RS. 1992. Lipopolysaccharide (LPS) partial structures inhibit
responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-
mediated pathway. J Exp Med. 176:485-94.
Koltover 1, Salditt T, Radier JO, Safinya CR. 1998. An inverted hexagonal phase of cationic
liposome-DNA complexes related to DNA release and delivery. Science. 281:78-81.
Kostenis E. 2004. Novel clusters of receptors for sphingosine-1-phosphate,
sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands. J
Cell Biochem. 92:923-36.
Krieg AM. 2002. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol.
20:709-60.
Kunkel SL, Wiggins RC, Chensue SW, Larrick J. 1986b. Régulation of macrophage tumor
Dans le document
Disponible à / Available at permalink :
(Page 111-131)